CUREVAC N V's ticker is CVAC and the CUSIP is N2451R105. A total of 84 filers reported holding CUREVAC N V in Q1 2023. The put-call ratio across all filers is 0.37 and the average weighting 0.2%.
Quarter-by-quarter ownership
Value | Shares | Weighting | ||||
---|---|---|---|---|---|---|
Q3 2023 | $21,214 | -49.6% | 3,106 | -23.1% | 0.00% | – |
Q2 2023 | $42,066 | +63.4% | 4,037 | +9.3% | 0.00% | – |
Q1 2023 | $25,740 | +70.5% | 3,693 | +47.5% | 0.00% | – |
Q4 2022 | $15,099 | +67.8% | 2,504 | +133.8% | 0.00% | – |
Q3 2022 | $9,000 | -85.0% | 1,071 | -75.7% | 0.00% | – |
Q2 2022 | $60,000 | -62.3% | 4,404 | -45.8% | 0.00% | – |
Q1 2022 | $159,000 | -37.9% | 8,123 | +8.9% | 0.00% | – |
Q4 2021 | $256,000 | -11.4% | 7,458 | +40.5% | 0.00% | -100.0% |
Q3 2021 | $289,000 | – | 5,308 | – | 0.00% | – |
Download |
Other shareholders
Name | Shares | Value | Weighting ↓ |
---|---|---|---|
Bill & Melinda Gates Foundation | 1,625,943 | $16,942,326 | 13.48% |
RA Capital Management | 12,245,955 | $127,602,851 | 2.41% |
Avidity Partners Management LP | 4,300,000 | $44,806,000 | 1.56% |
Camber Capital Management LP | 1,462,500 | $15,239 | 0.50% |
Eversept Partners, LP | 357,342 | $3,723,504 | 0.31% |
Ghisallo Capital Management LLC | 100,000 | $1,042,000 | 0.12% |
PLATINUM INVESTMENT MANAGEMENT LTD | 226,134 | $2,356,316 | 0.08% |
Green Alpha Advisors, LLC | 11,492 | $119,747 | 0.08% |
Alyeska Investment Group, L.P. | 899,423 | $9,371,988 | 0.07% |
Virtus ETF Advisers LLC | 10,692 | $111,411 | 0.07% |